Progress is being made to help lower the side effects of GLP-1 medication. A new study on NG101 (metopimazine mesylate), ...

There are also oral medications in phase III based on a possible action against tau, such as simufilam and ...

Transformative Financing worth up to $275 million from Top-Tier Institutional Healthcare Investors ---- Advancement of IkT-001Pro into a ...

Get detailed information on Garenoxacin Mesylate, including pronunciation, uses, dosage guidelines, indications, and instructions on how and when to take it and when to avoid it. The updated ...

Eribulin exerts its pharmacologic effects by binding to the plus ends of microtubules and suppressing microtubule growth, without affecting microtubule shortening, and by inducing the formation of ...

The FDA approved zolbetuximab (Vyloy) on October 18, 2024, as a first-line treatment for locally advanced unresectable or ...

Thus far, CETF has raised funding for clinical trials for drug candidates including Peginterferon lambda, a hepatitis D treatment, and Camostat mesylate, a protease inhibitor used to treat reflux ...

“骗保”案的道德困境治疗癌症的代价与医保的规范最近闹得沸沸扬扬的“骗保”案，最终很多涉案人员都被判处不同程度的刑罚。然而，很多人在谴责医保局和医保政策，今天从个人角度简单说说这件事的想法。涉案的药物叫做Osimertinib ...

Also Read | Bain Capital likely sells 1.1% stake in Axis Bank via block deal Earlier last week, Gland had announced that it had received approval for a generic Eribulin Mesylate Injection for the ...

NICE has said it expects to evaluate dozens of potential treatments for Alzheimer’s disease over the next few years. Elisabeth Mahase examines what we know about these drugs This year the National ...

Over the last 2 decades, significant progress has been made in our understanding of the genomics, tumor immune microenvironment, and immunogenicity of malignant melanoma. Historically, the prognosis ...